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Synthesis and characterization of bifunctional
dendrimers: preliminary use for the coating of
gold surfaces and the proliferation of human
osteoblasts (HOB)†
Edwin R. de Jong,abc Nicole Deloch,c Wolfgang Knoll,cd Ce´dric-Olivier Turrin,ab
Jean-Pierre Majoral,ab Anne-Marie Caminade*ab and Ingo Ko¨perce
Two diﬀerent novel families of bifunctional water-soluble dendrimers are synthesized, using the specific
functionalization of one function of the cyclotriphosphazene core. Dendrimers are grown from the
5 remaining functions, up to generation 2. Water-solubility is attained in the last step of the synthesis by
grafting either ammonium terminal groups or carboxylate terminal groups, on generations 1 and 2 of
these bifunctional dendrimers. 12 new compounds are synthesized and fully characterized, in particular
by multi-nuclear NMR. The function linked to the core is thioctic acid, suitable for grafting onto gold,
thus both types of water-soluble dendrimers can be used to coat gold surfaces. These macromolecular
assemblies are characterized by surface plasmon resonance (SPR). In a preliminary attempt, the gold
surfaces modified by either positively or negatively charged dendrimers are used for studying their
interaction with cells. Exposed to human osteoblast cells (OBC), the influence of the surface coatings on
the cell responses is investigated. Polycationic dendrimers provoke cell apoptosis, whereas negatively
charged dendrimers support cell adhesion and proliferation.
Introduction
Dendrimers1 are macromolecules with a regularly branched
and repetitive structure that are synthesized in an iterative
fashion. Due to their monodispersity, well-defined shape and
extremely high functionality, dendrimers are ideal nano-sized
objects for functional and biocompatible surface coatings.
Furthermore, dendrimers play an important role as versatile
tools in nano-medicine.2 In most cases dendrimers have
numerous but identical terminal groups. However, the demand
on their structural complexity is increasing,3 and there is a real
need for elaborating strategies toward bifunctional dendrimers.
Such an approach is particularly suitable for the functionaliza-
tion of the surface of materials at the nanometric scale.4
Extensive studies on cell–surface interactions have indicated
that surface properties such as hydrophilicity,5 surface charge,
surface energy,6 protein adsorption7 and surface topography and
morphology8 have a significant effect on these interactions.
Typically, cationic charges enhance cell attachment, possibly
through electrostatic attraction,9 as it was shown for instance
for human umbilical vein endothelial cells,10 and several other
types of cells.11 In addition, different cell types typically react
entirely differently to an environment;12 therefore a detailed
study on every surface coating is necessary. So far, dendrimers
have been used only occasionally for cell-attractive surface
coatings, despite the fact that their multivalency should enhance
the binding avidity towards cells. Rat neurons showed a high
affinity and proliferation rate on multilayered generation 4 (G4)
poly(phosphorhydrazone) dendrimer surfaces that were created
by a layer-by-layer deposition technique, with the neurons
showing a preference for positively charged outer layers.13
Human corneal epithelial cells and mouse fibroblasts showed
good adhesion on (G1–G4) dendronized surfaces with hydroxyl
extremities (non-ionic) of the polyamidoamine-based (PAMAM-
based) cascade structure.14 Human fibroblasts and myoblasts also
adhered on surfaces coated with D-glucose terminated dendrimers,15
and embryonic stem cells were maintained in an undifferentiated
state on the same surface.16 Recently, surfaces coated with
PAMAM generation 7 dendrimers modified with anti-epithelial
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cell adhesion molecules (one of the most commonly used
circulating tumour cells capturing agents) were efficiently used
for the capture of circulating tumour cells in peripheral blood.17
The surface attachment of osteoblast cells is of particular
interest for many biomedical applications. These cells interact
with the surface of bones, as they are continuously involved in
renewing and reshaping bone tissue. They are also important
when a foreign material needs to be inserted into the body, for
example in the case of implants. It was found that positively
charged amino-coated titanium surfaces enhanced the first steps
towards osteoblast adhesion, compared to negatively charged
surfaces.18 This could be related to the negative charge of
hyaluronan that is involved in the early adhesion process.19 TiOx
surfaces modified with biotinylated fibronectin (a partial amino-
acid sequence of an extracellular matrix protein) adsorbed on a
streptavidin-silane self-assembled multilayer were also found
eﬀective for osteoblast adhesion.20 However, to our knowledge,
no experiment to date involving osteoblasts has been carried out
with dendrimer coated surfaces.
Here we report the synthesis of two new series of bifunctional
dendrimers based on a phosphorus scaﬀold of the type poly-
(phosphorhydrazone), a well-established bio-compatible element.21
Gold surfaces are chosen to be coated by the dendrimers, as
any modification on this surface can be easily investigated
by surface plasmon resonance (SPR) spectroscopy and other
surface analytical techniques.22 For this purpose, the dendrimers
are functionalized with one dithiolane group linked to the core,
suitable for the formation of self-assembled monolayers on
gold surfaces, due to the well-known aﬃnity of gold to thiols.
Positively or negatively charged functions are used as terminal
groups, to confer a hydrophilic character to the surface of the
dendrimer,23 and thus to the coated surface. As it has been
already shown that the nature of the charges (positive or negative)
strongly influences the behaviour of the cells, the presence of
charges as terminal groups of dendrimers will enable a comparison
with these data.18 The formation of a self-assembled monolayer on
a gold substrate is characterized by surface plasmon resonance
(SPR) spectroscopy. In a preliminary attempt, the coated surfaces
are exposed to human osteoblast (HOB) cells and their adhe-
sion and proliferation are studied by optical microscopy and
biochemical assays.
Results and discussion
Synthesis and characterization of bifunctional dendrimers
Hexachlorocyclotriphosphazene is an interesting core for den-
drimers, as it possesses 6 functions for growing the branches,
instead of 3 or 4 for most classical cores. Furthermore, we have
previously shown that it is possible to diﬀerentiate one function
among six, aﬀording AB5-type compounds, suitable to elaborate
non symmetrical dendrimers24 or highly dense dendrimers.25
The possibility of diﬀerentiating the reactivity of each Cl in
P(X)Cl2 groups (X = S, O, or NR)
26 is particularly relevant for the
design of new bifunctional dendrimers. The A function is the
dithiolane group for grafting onto the gold surface, and the B
functions are aldehydes, which are suitable starting points for
the synthesis of the branches of poly(phosphorhydrazone)
dendrimers,27 and further functionalizations. The reaction of
phenols with P–Cl functions is the most convenient reaction
(easy and quantitative) for the functionalization of phosphorus
dendrimers under basic conditions. Thus we used hydroxybenz-
aldehyde as the B group and we grafted tyramine to thioctic acid
by peptide coupling to elaborate the A group, which contains a
phenol also (compound 1, Scheme 1).
In order to obtain the AB5 core, two strategies can be
envisaged: either by first grafting one dithiolane derivative 1
onto the core followed by the reaction of 5 equivalents of hydroxy-
benzaldehyde (Way a, Scheme 1) or grafting first 5 equivalents of
hydroxybenzaldehyde then the dithiolane derivative 1 (Way b,
Scheme 1). We tested both the strategies. Way a yielded the
expected compound 2 as the major product, characterized by the
presence of one doublet at 22.4 ppm in the 31P NMR spectrum,
and a pseudo triplet at 12.2 ppm (2JPP = 64 Hz), characteristic of a
single substitution on N3P3Cl6. However, the
31P NMR spectrum
displays also the presence of small impurities (about 5%) that
Scheme 1 Synthesis of the dithiolane derivative 1, and two strategies for its grafting to the cyclotriphosphazene core. Only Way b aﬀords pure
compounds.
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could not be removed in the purification process. Way b yielded
cleanly the pentaaldehyde 3,28 characterized by the presence
of a pseudo triplet at 20.8 ppm and a doublet at 5.1 ppm (2JPP =
84 Hz) in the 31P NMR spectrum. The grafting of compound 1 in
the second step induces the disappearance of these signals and
the appearance of a pseudo singlet at 7.4 ppm for compound
4-G0. We also tried to obtain compound 4-G0 by continuing
the process of Way a, i.e. by reacting 5 equivalents of hydroxy-
benzaldehyde with compound 2. The reaction worked, but
some impurities from the previous step could not be removed.
Thus, only compound 4-G0 obtained through Way b was used in
the subsequent steps (Scheme 1).
The condensation of 5 equivalents of H2NNMeP(S)Cl2
resulted in the first generation bifunctional dendrimer 5-G1.
The completion of the reaction is shown by the disappearance
of the signals corresponding to the aldehydes both in 1H and
13C NMR. Compound 5-G1 is the starting material for pursuing
the growth of the branches. Compound 5-G1 is reacted with 10
equivalents of hydroxybenzaldehyde. The completion of the
reaction aﬀording 4-G1 is detected by
31P NMR, which displays
the disappearance of the intermediate singlet at 69 ppm,
corresponding to the monosubstitution (P(S)Cl(OC6H4CHO))
on behalf of the appearance of a singlet at 60.4 ppm, corres-
ponding to the full substitution. Starting from compound 4-G1,
the second generation of the bifunctional dendrimer is obtained
by the condensation with H2NNMeP(S)Cl2. Compound 5-G2 is
isolated and characterized, as 5-G1 previously. It is in particular
characterized in 31P NMR by the presence of three singlets
at 8.3 ppm (N3P3), 61.9 ppm (the 5 PQS groups of the first
generation), and 62.8 ppm (the 10 PQS groups of the second
generation). Compound 5-G2 is then reacted with 4-hydroxy-
benzaldehyde to aﬀord dendrimer 4-G2 (Scheme 2). In this case
also, 31P NMR displays the appearance of the intermediate
singlet at 69 ppm, corresponding to the monosubstitution,
which disappears when the reaction has reached completion.
All these steps are compatible with the presence of the dithiolane
linked to the core, as shown by 1H and 13C NMR, with unchanged
signals corresponding to the CH and CH2 groups of the
5-membered ring.
Dendrimers 4-G1, 4-G2, 5-G1, and 5-G2 are the precursors of
the hydrophilic bifunctional dendrimers suitable for grafting
onto the gold surface. For this purpose, two diﬀerent strategies
have been applied. For obtaining positively charged dendrimers,
N,N-diethylethylenediamine is reacted with the P(S)Cl2 terminal
groups (1 diamine per Cl). HCl generated in the reaction is
trapped by the tertiary amine moieties,29 aﬀording directly the
water-soluble bifunctional dendrimer 6-G1 from 5-G1. As the
protonation of the tertiary amine is reversible, the percentage
of protonation varies depending on the media, and in parti-
cular depending on the pH.13 The simultaneous presence of
the two types of terminal groups is clearly detected by 1H and
13C NMR, in particular for the CH3 groups of NH
+(CH2CH3)2
(major, d 1H = 1.33 ppm (t), d 13C = 7.8 ppm) and N(CH2CH3)2
(minor, d 1H = 1.26 ppm (t), d 13C = 9.0 ppm). The same type of
reaction is applied to compound 5-G2, used as a precursor
for the synthesis of the water-soluble bifunctional dendrimer
6-G2 (Scheme 3).
Compound 4-G1 is the starting point for aﬀording another
type of water-soluble (negatively charged) bifunctional dendrimer
suitable for grafting onto gold surfaces. For this purpose, a
Doebner-like reaction is carried out with malonic acid in
pyridine with a catalytic amount of piperidine.30 This reaction
aﬀords compound 7-G1 ending with carboxylic acids. The
characterization is performed at this step. The completion of
the reaction is shown by 1H NMR, with the disappearance of
the signal corresponding to the aldehydes on behalf of two
doublets at 6.43 and 7.19 ppm (3JHH = 15.9 Hz), corresponding
to the alkene groups. Compound 7-G1 ending with carboxylic
acids is not soluble in water, contrarily to its sodium salt,
obtained by the addition of NaOH. Finally, compound 4-G2 is
used as a precursor for dendrimer 7-G2, obtained from the
reaction with malonic acid (Scheme 4 displays the full structure
of compound 7-G2, after reaction with NaOH).
31P NMR
displays the presence of 3 signals corresponding to the core
N3P3 (8.4 ppm) and the PQS groups of the first (62.4 ppm) and
second (62.0 ppm) layers. Interestingly, all these steps also are
compatible with the presence of the dithiolane function linked
to the core. Indeed, it is by far not trivial to have at each step of
Scheme 2 Synthesis of bifunctional dendrimers having one dithiolane function at the core, and either Cl (5-G1 and 5-G2) or CHO (4-G1 and 4-G2)
terminal functions.
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the multi-step synthesis of dendrimers two types of functions
that do not interfere.
Gold surface coating with the bifunctional dendrimers
Thin glass slides commonly used for optical microscopy were
coated with thin layers of chromium (5 nm) and gold (48 nm).
In the first attempt, dendrimers 6-G1 and 7-G1 were used in
solution in water. A self-assembled layer of the bifunctional
first generation dendrimer was formed on the gold surfaces.
The dendrimers attach to the gold surface through the dithiolane
moiety at the core, which strongly binds to gold via quasi-covalent
bonds.31 The successful assembly process was characterized by
contact angle and surface plasmon resonance (SPR) measure-
ments. After about five hours, the binding process was com-
pleted. Fig. 1 displays the SPR angular scans of a gold sample
coated with either dendrimer 6-G1 or dendrimer 7-G1. Assuming
a refractive index of 1.532 for the dendrimer layer, film thick-
nesses of about 1.0 nm were obtained. This low value suggests
that the hydrophobic interior of the dendrimers collapses upon
contact with the aqueous environment. This is in agreement
with the behaviour of phosphorus dendrimers in water mea-
sured earlier.33 Analogous experiments were attempted with
the second generations of the bifunctional dendrimers 6-G2
and 7-G2 but failed, presumably due to the protection/shielding
of the dithiolane induced by the branches of the dendrimers,
which prevents the interaction with the gold surface.
Water contact angle measurements (see ESI†) showed con-
tact angles of approximately 501 for both the polycationic and
polyanionic first generation dendrimer coatings. This value
suggests that the hydrophobic interior of the dendrimers is
exposed to the aqueous phase, resulting in a film without
extreme polarity for both 6-G1 and 7-G1.
Human osteoblast (HOB) cell proliferation on dendrimer
functionalized surfaces
In order to demonstrate the potential utility of the new water
soluble bifunctional dendrimers in biology, the dendrimer-
coated glass substrates were exposed to a cell culture of human
osteoblast HOB cells and the proliferation behaviour of these
cells was studied optically. Optical microscopy is a valuable
method for assessing cell morphology during cell adhesion and
proliferation. During the first 24 hours, the cells were observed
several times in order to follow the cell attachment and
spreading process. The HOB cells were seeded to the dendrimer
coated substrates and spread similarly on the polycationic, the
polyanionic and on the control substrates (Au coated glass and
the petri dish plastic). After 24 hours, most of the cells had
adopted their typical, stretched shape and initiated cell–cell
contact. These contacts are vital for their survival and are
usually made within the first few days.
The cell proliferation was followed until a confluence of
80–100%. After the first few days, the cells started to show a
different behaviour on the samples coated with positively
charged dendrimers 6-G1 (Fig. 2). On the negatively charged
dendrimers 7-G1 as well as on the control substrates, the cells
attached, stretched and proliferated normally. On the positively
charged dendrimers 6-G1, however, the cells proliferated less,
resulting in many rounded cells and a low surface coverage.
The rounded cells were probably dead cells, which concurs with
the decreased proliferation rate. A few rounded cells were
observed on the other samples (polyanionic 7-G1 and control),
but most of them spread again. This is a common process and
is related to mitosis. Moreover, on the positively charged
dendrimers 6-G1 it was observed that all cells were retracting
on longer time scales.
The microscopy images of the cells on positively charged
dendrimer have been studied in more detail for the visualiza-
tion of the dead cells (Fig. 3). Most cells died through apoptosis
(‘‘programmed’’ cell death), rather than necrosis (traumatic cell
death). It was possible to observe the main apoptotic hallmarks
by their appearance: chromatin condensation (3A), cell retrac-
tion (3B–3C), membrane blebbing (3C) and the final phase
where apoptotic bodies are formed (3C–3D). Cell shrinkage
manifests itself with an irregular cell shape and shady areas
around the cells. Membrane blebbing is an advanced form of
cell shrinkage, where as a result the membrane starts to deform
heavily, showing large quasi-spherical protrusions. It manifests
itself as small blobs attached to the cell.34 Apoptotic bodies
are the leftovers of the entire process and can be identified under
the microscope (phase contrast) as condensed, ring-like features.
Scheme 3 Synthesis of water-soluble bifunctional dendrimers having one dithiolane function at the core, and 10 (6-G1) or 20 (6-G2) ammonium
terminal groups.
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Fig. 3a and b were obtained after staining cells with DAPI
(40,6-diamidino-2-phenylindole dihydrochloride), which selec-
tively reveals the location of the genetic material. By overlaying
the obtained fluorescence images with the regular microscopy
images, it was possible to distinguish between healthy cells
(nucleus stained blue) and apoptotic cells (diffuse blue stain
throughout the cell, Fig. 3b) and to recognize apoptotic hall-
marks such as chromatin condensation and breakdown of the
nuclear envelope.
The proliferation behaviour and health status of the cells
have been quantified in terms of cell viability (Fig. 4A). The
viability was determined as the ratio between the number of
Scheme 4 Synthesis of water-soluble bifunctional dendrimers having one dithiolane function at the core, and 10 (7-G1) or 20 (7-G2) ammonium
terminal groups.
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living and total cells. A significant diﬀerence was observed
between cells that grew on polycationic 6-G1 or on polyanionic
7-G1 dendrimers. For each sample, values obtained for cells
adhered on the petri dish plastic served as a positive internal
reference. Cells on polyanionic dendrimers 7-G1 and positive
control samples showed a very similar behaviour. This indicates
that polyanionic dendrimers 7-G1 did not aﬀect HOB cell growth
as compared to any reference sample. In contrast, polycationic
dendrimer 6-G1 coatings had cytotoxic eﬀects, resulting in a
decreased cell number and viability.
A caspase 3/7 specific assay was performed, where the
luminescence of Luciferase directly reflects the presence
and/or activity of the caspases 3 and 7 (Fig. 4B). These enzymes
are only active when a cell undergoes apoptosis. The polyanionic
dendrimers 7-G1 and the control substrates showed similar
low values, clearly indicating that cells were not apoptotic. The
polycationic dendrimers 6-G1, however, did strongly provoke
apoptosis, confirming the microscopy observations.
Fig. 1 SPR angular scan of gold samples. Up: with and without a 6-G1
coating; down: with and without a 7-G1 coating.
Fig. 2 HOB cell proliferation on control, polyanionic (7-G1) and polycationic
(6-G1) samples at diﬀerent stages.
Fig. 3 Hallmarks of apoptosis among HOB cells were only found on
positively charged dendrimers (6-G1). (a) Fluorescence image of a DAPI
stained cell nucleus; (b) fluorescence and optical microscopy overlay
image of a DAPI stained cell; (c) and (d) optical microscopy of cells. All
images were recorded after approximately 280 hours.
Fig. 4 Proliferation and apoptosis quantified on diﬀerent dendrimer
(negatively charged 7-G1; positively charged 6-G1) coated surfaces: (A) viability,
(B) caspase 3/7 activity assay. These values have been obtained after approxi-
mately 280 hours of cell adhesion and proliferation.
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Water-soluble positively charged dendrimers (polyamido
amine type) and linear polymers have been described to induce
apoptosis among many cell types,35,36 mostly through uptake by
the cells. Polyamidoamine dendrimers and linear polycations were
found to diﬀuse through the cell membrane and to integrate into
the mitochondrial membrane. They compromised the integrity of
organelles resulting in a sudden cytochrome c release, which
indirectly triggers apoptosis. Furthermore, the amine content as
well as the amine substitution degree (primary-quaternary) seems
to aﬀect the cytotoxicity; higher substitution degrees were found
to be more lethal.35,37 In contrast to these experiments, the
dendrimers in the current study were attached to a solid support.
There are only few reports on apoptosis specifically induced by
surface coatings.38 In general, cells are unaﬀected by amines or by
positively charged surfaces. In fact, cells adhere preferentially to
cationic surfaces due to the stronger electrostatic interaction
between the surface and the cell membrane. Furthermore, similar
dendrimers with diethyl ammonium groups have been electro-
statically attached to a substrate and they showed no apoptotic
eﬀect on neuronal cells.13
Our results are in marked contrast with several previous
reports studying the influence of the charges on the behaviour
of cells, including osteoblasts. Indeed, a lower osteoblast cell
proliferation on COOH-terminated titanium films was observed
compared with NH2-terminated titanium films,
18 and recent
observations described in the literature with positively charged
polymeric-dendritic poly(lysine)-coated surfaces39 also empha-
size the positive role of such a surface on the adhesion of cells.
However, the topology of dendrimers is diﬀerent from that of
small molecules and of polymers, and it is well-known that
subtle changes in the periphery of dendrimers may deeply
modify their properties and cytotoxicity.40 In the case of phos-
phorus dendrimers, positively charged dendrimers with the
same ammonium terminal groups than 6-G1 (but without the
thioctic arm) have been used in many cases in contact with
cells, as transfection agents,29 as anti-HIV agents,41 as in vivo
anti-prion agents,42 and as agents against the aggregation of
Alzheimer’s peptides.43 No acute toxicity was observed, except
in the case of human mononuclear blood cells, the polycationic
dendrimers induce changes in their morphology, and also
the loss of cell attachment properties.44 Negatively charged
phosphorus dendrimers have many properties for modulating
in vitro the response of the human immune system,45 and have also
anti-inflammatory properties in vivo.46 Phosphorus dendrimers
ending by the same carboxylate groups as those of 7-G1 have been
already used as non-covalent carriers of anti-HIV aminolactitol,47
and in vivo for the delivery of an anti-hypertensive drug,48
without an acute toxicity eﬀect.
Since only surfaces covered with the polycationic dendrimers
6-G1 were cytotoxic to HOB cells, the specific interaction between
the surface bound amine groups and the HOB cells caused an
activation of the apoptotic pathway. Stronger electrostatic attrac-
tion between cells and substrate can be advantageous for cell
initial adhesion, but most cells require mobility and cell–cell
contact for proper proliferation, which is inhibited by a stronger
attraction, and may account for the observed apoptosis.
Conclusions
Water-soluble generation 1 and generation 2 bifunctional den-
drimers with 10 or 20 peripheral charges and one thioctic acid
function linked to the core were synthesized and characterized.
Only the first generations could be bound to a gold surface via
the dithiolane moiety. Such a function is a convenient alter-
native to classical thiols for interaction with gold, and may find
use in other fields, such as the coating of gold nanoparticles,
which have many biological applications.49 These functionalized
gold surfaces were exposed to human osteoblast (HOB) cells and
probed for their ability to sustain cell proliferation. Diethyl-
ammonium terminated polycationic dendrimers induced apop-
tosis among HOB cells, probably triggered by the strong attrac-
tive electrostatic interaction between the cells and substrate.
A caspase 3/7 activity assay confirmed the apoptotic hallmarks
observed by optical microscopy. The carboxyl terminated
polyanionic derivatives showed no significant eﬀect on the
proliferation of HOB cells. The two diﬀerent dendrimer coat-
ings are thus potential candidates for application in coatings of
biomedical devices, if a specific cell response to the coating is
required. Implants require strong cell adhesion and good cell
proliferation, while other applications require a non-adhesive
coating. Contrarily to polymers classically used for such purposes,
the high peripheral functionality, the monodispersity and well-
defined shape of dendrimers allow for fine-tuning the surface
properties, with high reproducibility, as required for ideal cell–
surface interactions.
Experimental
Syntheses of the dendrimers
All reactions were carried out under an argon atmosphere and
in freshly distilled solvents. All column chromatography experi-
ments were carried out with silica gel 60 as the static phase.
All starting compounds were purchased from Aldrich, Merck
or Fluka and used as received. Solvents were dried and distilled
prior to use. The references for NMR are Me4Si for
1H and
13C NMR, H3PO4 (85% in water) for
31P NMR. The numbering
used for NMR assignment is shown in Fig. 5. p-Hydroxybenz-
aldehyde sodium salt was prepared by ion exchange with NaH.
H2NNMeP(S)Cl2
50 and compound 328 were prepared as published
previously.
Fig. 5 Numbering used for NMR assignment.
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Compound 1. In a Schlenk flask under an argon atmo-
sphere, thioctic acid (2.509 g, 12.2 mmol, 1.23 eq.) and DIPEA
(diisopropylethylamine, 2.2 mL, 12.6 mmol, 1.27 eq.) were
dissolved in 20 mL of dry dichloromethane and cooled down
to 20 1C. A 20 mL DMF solution of TBTU (O-(Benzotriazol-1-
yl)-N,N,N0,N0-tetramethyluronium tetrafluoroborate, 3.634 g,
11.3 mmol, 1.14 eq.) was added dropwise and the mixture
was stirred for 30 minutes at room temperature. This mixture
was added to a 10 mL DMF suspension of tyramine (1.356 g,
9.9 mmol, 1.0 eq.) and the reaction was completed overnight at
room temperature. The solvents were evaporated under
reduced pressure. The product was diluted in dichloromethane
and washed twice with a saturated aqueous NaHCO3 solution
and once with brine and finally dried on Na2SO4. The crude
product was purified by column chromatography (1% MeOH in
CHCl3). This procedure quantitatively yielded the product 1 as a
yellow solid. 1H-NMR (250 MHz, CDCl3, d): 1.39 (m, 2H, C
(3)H2),
1.62 (m, 4H, C(2)H2, C
(4)H2), 1.87 (m, 1H, C
(6)H2), 2.16 (t,
3JHH =
7.4 Hz, 2H, C(1)H2CO), 2.40 (m, 1H, C
(6)H2), 2.72 (t,
3JHH =
7.0 Hz, 2H, CH2Ar), 3.12 (m, 2H, C
(7)H2S), 3.48 (m, 3H, C
(5)H–S,
CH2N), 6.06 (br s, 1H, NH), 6.81 (d,
3JHH = 8.4 Hz, 2H, CT
2H),
7.00 (d, 3JHH = 8.4 Hz, 2H, CT
3H), 7.98 (br s, 1H, OH). 13C{1H}-
NMR (75.5 MHz, CDCl3, d): 25.4 (C
(2/4)H2), 28.8 (C
(3)H2), 34.5
(C(2/4)H2), 34.7 (CH2Ar), 36.5 (C
(1)H2CO), 38.5 (C
(7)H2S), 40.3
(C(6)H2), 41.0 (CH2NH), 56.5 (C
(5)H), 115.7 (CT
2), 129.7 (CT
3,4),
155.3 (CT
1), 173.7 (NCO).
Compound 2. A solution of compound 1 (0.506 g,
1.557 mmol, 1 eq.) in THF (50 mL) was added dropwise to a
mixture of N3P3Cl6 (0.648 g, 1.868 mmol, 1.2 eq.) and Cs2CO3
(1.015 g, 3.114 mmol, 2.0 eq.) in THF (200 mL) at 20 1C. The
resulting mixture was allowed to reach slowly room tempera-
ture and was stirred overnight. The mixture was concentrated,
and then centrifuged. The solution was taken and evaporated
to dryness. The product was tentatively purified by column
chromatography on silica gel (hexane/ethylacetate as eluent).
Compound 2 was obtained as a yellow oil (0.40 g, 0.629 mmol,
40% yield), containing about 5% of impurities, as detected by
31P and 1H NMR. 31P{1H}-NMR (101.3 MHz, CDCl3, d): 12.2
(pseudo t, 2JPP = 64 Hz, PCl), 22.4 (pseudo d,
2JPP = 64 Hz, PCl2).
1H-NMR (250 MHz, CDCl3, d): 1.44 (m, 2H, C
(3)H2), 1.66 (m, 4H,
C(2)H2, C
(4)H2), 1.90 (m, 1H, C
(6)H2), 2.16 (t,
3JHH = 7.4 Hz, 2H,
C(1)H2CO), 2.46 (m, 1H, C
(6)H2), 2.84 (t,
3JHH = 7.0 Hz, 2H,
CH2Ar), 3.15 (m, 2H, C
(7)H2S), 3.52 (m, 3H, C
(5)H–S, CH2N), 5.68
(br s, 1H, NH), 7.26 (br s, 4H, CT
2,3H).
Bifunctional dendrimer 4-G0. A 150 mL THF solution of 3
(2.82 g, 3.64 mmol, 1.0 eq.) and Cs2CO3 (1.79 g, 5.46 mmol,
1.5 eq.) was cooled down to 0 1C. A 20 mL THF solution of 1
(1.30 g, 4.00 mmol, 1.1 eq.) was added and the reaction mixture
was stirred overnight at room temperature. The mixture was
centrifuged (30 min, 10k rpm), the salts were removed, and the
THF was evaporated. The product was purified by column
chromatography using an increasing gradient of ethyl acetate/
hexane starting at a 1 : 1 ratio. This yielded the dendrimer 4-G0
(2.91 g, 2.72 mmol, 75%) as a yellow oil. 31P{1H}-NMR (101.3 MHz,
CDCl3, d): 7.4 (m, N3P3).
1H-NMR (250 MHz, CDCl3, d): 1.41
(m, 2H, C(3)H2), 1.62 (m, 4H, C
(2)H2, C
(4)H2), 1.90 (m, 1H, C
(6)H2),
2.12 (t, 3JHH = 7.4 Hz, 2H, C
(1)H2CO), 2.40 (m, 1H, C
(6)H2), 2.73
(t, 3JHH = 7.0 Hz, 2H, CH2Ar), 3.11 (m, 2H, C
(7)H2S), 3.50 (m, 3H,
C(5)H–S, CH2N), 5.81 (br s, 1H, NH), 6.82 (m, 2H, CT
2H), 7.02
(m, 2H, CT
3H), 7.28 (m, 10H, C0
2H), 7.80 (m, 10H, C0
3H), 9.95
(2s, 5H, CHO). 13C{1H}-NMR (62.9 MHz, CDCl3, d): 25.3
(C(2/4)H2), 28.9 (C
(3)H2), 34.6 (C
(2/4)H2), 35.1 (CH2Ar), 36.4
(C(1)H2CO), 38.5 (C
(7)H2S), 40.3 (C
(6)H2), 40.5 (CH2NH), 56.4
(C(5)H), 120.7 (CT
2), 121.3 (C0
2), 129.9 (CT
3), 131.4 (C0
3), 133.7
(C0
4), 136.6 (CT
4), 154.7 (C0
1, CT
1), 172.8 (NCO), 190.5 (CHO).
Bifunctional dendrimer 5-G1. A 56.7 mL 0.24 M solution of
H2NNMePSCl2 (1.26 mmol, 5 eq.) in chloroform was added to a
50 mL solution of 4-G0 (2.906 g, 2.72 mmol, 1.0 eq.) in chloro-
form. After one night the amount of solvent was reduced to a
few milliliters and then added dropwise to a large amount of
pentane. The product precipitated readily and the solvent was
filtered oﬀ by means of a canula. This process was repeated three
times. Dendrimer 5-G1 was obtained as a white (pale yellow) solid
with a yield of 4.68 g (2.50 mmol, 92%). 31P{1H}-NMR (121.5 MHz,
CDCl3, d): 8.3 (m, N3P3), 62.4/62.6 (s, P1).
1H-NMR (300 MHz,
CDCl3, d): 1.41 (m, 2H, C
(3)H2), 1.63 (m, 4H, C
(2)H2, C
(4)H2), 1.85
(m, 1H, C(6)H2), 2.12 (t,
3JHH = 7.2 Hz, 2H, C
(1)H2CO), 2.45 (m, 1H,
C(6)H2), 2.77 (t,
3JHH = 7.2 Hz, 2H, CH2Ar), 3.14 (m, 17H, C
(7)H2S,
P1–N–CH3), 3.45 (m, 3H, C
(5)H–S, CH2N), 5.64 (br s, 1H, NH),
6.91–7.06 (m, 12H, CT
2H, C0
2H), 7.58–7.65 (m, 12H, CT
3H, C0
3H),
7.70 (s, 5H, CHQN). 13C{1H}-NMR (75.5 MHz, CDCl3, d): 25.4
(C(2/4)H2), 28.9 (C
(3)H2), 32.0 (d,
2JCP = 13.2 Hz, P1–N–CH3), 34.6
(C(2/4)H2), 35.2 (CH2Ar), 36.4 (C
(1)H2), 38.5 (C
(7)H2S), 40.3 (C
(6)H2),
40.7 (CH2NH), 56.5 (C
(5)H), 121.1 (CT
2), 121.4 (C0
2), 128.6 (C0
3),
129.7 (CT
3), 131.3 (C0
4), 135.9 (CT
4), 140.8 (br d, 3JCP = 20.1 Hz,
CHQN–N–P1), 149.0 (CT
1), 151.7 (C0
1), 173.0 (NCO).
Bifunctional dendrimer 6-G1. N,N-Diethylethylenediamine
(765 mL, 5.35 mmol, 10 eq.) was added dropwise to a 150 mL
THF solution of 5-G1 (1.002 g, 5.36 mmol, 1.0 eq.). The reaction
was left to stir at room temperature overnight. A white solid
appeared during the reaction. The precipitate was washed with
dry THF and diethylether and was lyophilized. Dendrimer 6-G1
was obtained as a white powder (1.226 g, 405 mmol, 76%).
31P{1H}-NMR (121.5 MHz, CD3OD, d): 8.5 (s, N3P3), 70.4 (s, P1).
1H-NMR (300 MHz, CD3OD, d): 1.26 (t,
3JHH = 7.2 Hz, about 10H,
NCH2CH3), 1.33 (t,
3JHH = 7.2 Hz, about 50H, N
+CH2CH3), 1.40
(m, 2H, C(3)H2), 1.66 (m, 4H, C
(2)H2, C
(4)H2), 1.85 (m, 1H,
C(6)H2), 2.16 (t,
3JHH = 7.2 Hz, 2H, C
(1)H2CO), 2.43 (m, 1H,
C(6)H2), 2.78 (t,
3JHH = 7.2 Hz, 2H, CH2Ar), 2.97 (q,
3JHH = 7.2 Hz,
about 6H, NCH2CH3), 3.12 (m, 2H, C
(7)H2S), 3.15–3.50 (m, 91H,
C(5)H–S, CH2N, P1–N–CH3, N
+CH2CH3), 6.82 (m, 2H, CT
2H),
7.00–7.11 (m, 12H, CT
3H, C0
2H), 7.70–7.81 (m, 15H, C0
3H,
CHQN–N–P1).
13C{1H}-NMR (75.5 MHz, CD3OD, d): 7.8
(N+CH2CH3), 9.0 (NCH2CH3), 25.4 (C
(2/4)H2), 28.5 (C
(3)H2), 31.4
(2d, 2JCP = 10.6 Hz, P1–N–CH3), 34.4 (C
(2/4)H2), 35.5 (CH2Ar),
36.2 (C(1)H2CO, CH2–N–P1), 38.0 (C
(7)H2S), 40.0 (C
(6)H2),
40.4 (CH2NHCO), 49.0 (N–CH2CH3), 52.2 (d,
3JCP = 6.9 Hz,
P1–N–CH2CH2), 56.5 (C
(5)H–S), 120.5 (CT
2), 120.9 (C0
2),
128.0 (C0
3), 129.7 (CT
3), 133.2 (C0
4), 136.4 (CT
4), 137.7 (m,
CHQN–N–P1), 150.8 (m, C0
1, CT
1), 174.5 (NCO).
Bifunctional dendrimer 4-G1. In a Schlenk tube under
an argon atmosphere were mixed 4.68 g of 5-G1 (2.50 mmol,
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1.0 eq.), 7.00 g of p-hydroxybenzaldehyde (57.4 mmol, 23 eq.,
excess to accelerate the reaction) and 16.25 g of Cs2CO3
(50 mmol, 20 eq.) and dissolved in 250 mL of THF. The reaction
mixture was stirred overnight at room temperature. The mixture
was centrifuged, concentrated under reduced pressure, precipi-
tated from pentane/ether and finally put on a small silicagel
column to separate the product from the excessive amount of
p-hydroxybenzaldehyde. This procedure yielded 5.97 g (88%) of
dendrimer 4-G1 in the form of a pale yellow solid.
31P{1H}-NMR
(101.3 MHz, CDCl3, d): 8.2 (s, N3P3), 60.4 (s, P1).
1H-NMR
(250 MHz, CDCl3, d): 1.38 (m, 2H, C
(3)H2), 1.57 (m, 4H, C
(4)H2,
C(2)H2), 1.86 (m, 1H, C
(6)H2), 2.06 (m, 2H, CH2CO), 2.38 (m, 1H,
C(6)H2), 2.70 (m, 2H, CH2Ar), 3.06 (m, 2H, C
(7)H2S), 3.36 (m, 18H,
C(5)H–S, CH2NH, P1–N–CH3), 5.98 (s, 1H, NH), 6.96 (m, 2H,
CT
2H), 7.03 (m, 12H, C0
2H, CT
3H), 7.34 (m, 20H, C1
2H), 7.56
(m, 10H, C0
3H), 7.65 (s, 3H, CHQN–N), 7.67 (s, 2H, CHQN–N),
7.81 (m, 20H, C1
3H), 9.93 (s, 10H, CHO). 13C{1H}-NMR (62.9 MHz,
CDCl3, d): 25.4 (C
(2/4)H2), 28.8 (C
(3)H2), 32.8 (d,
2JCP = 12.8 Hz,
P1–N–CH3), 34.6 (C
(2/4)H2), 35.0 (CH2Ar), 36.2 (C
(1)H2), 38.4
(C(7)H2S), 40.2 (C
(6)H2), 40.5 (CH2NH), 56.5 (C
(5)H–S), 121.0
(CT
2), 121.4 (C0
2), 121.8 (d, 3JCP = 6.8 Hz, C1
2), 128.3 (C1
3),
129.7 (CT
3), 131.4 (C1
4), 131.8 (C0
3), 133.7 (C0
4), 135.8 (CT
4),
139.7 (d, 3JCP = 13.4 Hz, CHQN–N–P1), 151.5 (d,
2JCP = 7.0 Hz,
C0
1, CT
1), 155.0 (d, 2JCP = 7.0 Hz, C1
1), 172.8 (NCO), 190.7 (CHO).
Bifunctional dendrimer 7-G1. Compound 4-G1 (1.00 g,
0.367 mmol, 1.0 eq.), 0.95 g of malonic acid (9.17 mmol,
25 eq.) and 45 mL of freshly distilled (on CaH2) piperidine
(0.459 mmol, 1.25 eq.) were dissolved in 15 mL of freshly
distilled pyridine (on CaH2) and left to stir overnight at 95 1C.
The mixture was then refluxed for 15 minutes more to remove
the CO2 and let to cool down before precipitating it on ice
cooled HCl (37%). The precipitate was subsequently washed
with water (3 times) and ether (2 times) and dried under the
vacuum. In order to obtain the sodium salt, the product was
poured into water and 12.25 mL of 0.1996 M NaOH (aq) (excess)
was added dropwise yielding a slightly turbid solution. The
overall yield was 0.811 g of the sodium salt 7-G1 (241 mmol,
66%). The NMR spectra were recorded before ion exchange
(COOH terminated dendrimer). 31P{1H}-NMR (121.5 MHz,
DMSO-d6, d): 8.4 (s, N3P3), 62.0 (s, P1).
1H-NMR (300 MHz,
DMSO-d6, d): 1.22 (m, 2H, C
(3)H2), 1.42 (m, 4H, C
(4)H2, C
(2)H2),
1.75 (m, 1H, C(6)H2), 1.96 (m, 2H, CH2CO), 2.29 (m, 1H, C
(6)H2),
2.58 (m, 2H, CH2Ar), 3.04 (m, 2H, C
(7)H2S), 3.27–3.41 (m,
18H, C(5)H–S, CH2NH, P1–N–CH3), 5.35 (br s, 1H, NH), 6.43
(d, 3JHH = 15.9 Hz, 10H, CHQCHCO2), 6.80 (m, 2H, CT
2H), 7.03
(m, 12H, CT
3H, C0
2H), 7.16 (m, 20H, C1
2H), 7.19 (d, 3JHH =
15.9 Hz, 10H, CHQCHCO2), 7.61 (m, 30H, C0
3H, C1
3H), 7.85
(s, 3H, CHQN–N), 7.91 (s, 2H, CHQN–N), 12.4 (s, 10H, COOH).
13C{1H}-NMR (75.5 MHz, DMSO-d6, d): 25.5 (C
(2/4)H2), 28.8
(C(3)H2), 33.4 (2d,
2JCP = 11.9 Hz, P1–N–CH3), 34.6 (C
(2/4)H2),
34.9 (CH2Ar), 35.7 (C
(1)H2), 38.5 (C
(7)H2S), 56.5 (C
(5)H–S), 119.9
(Ar–CHQCH), 120.7 (CT
2), 121.4 (C0
2), 121.8 (d, 3JCP = 4.1 Hz,
C1
2), 128.7 (C0
3), 129.0 (CT
3), 130.2 (C1
3), 132.2 (C1
4), 132.4 (C0
4),
137.2 (CT
4), 141.1 (CHQN–N), 143.1 (Ar–CHQCH), 148.4 (CT
1),
151.0 (C0
1), 151.7 (C1
1), 167.9 (COOH), 172.3 (NCO). (C(6)H2 and
CH2NH hidden by DMSO).
Bifunctional dendrimer 5-G2. To an ice cooled 70 mL CHCl3
solution of 3.97 g of compound 4-G1 (1.46 mmol, 1.0 eq.) were
added 64 mL (0.24 M, 15.3 mmol, 10.5 eq.) of H2NNMeP(S)Cl2
in CHCl3. The reaction mixture was stirred at room temperature
for two hours and checked with NMR for completion. The
volume of CHCl3 was reduced and the mixture was precipitated
from pentane several times until the excess of H2NNMeP(S)Cl2
was completely removed. Dendrimer 5-G2 was obtained as a
pale yellow solid in 94% yield (5.97 g, 1.37 mmol). 31P{1H}-NMR
(121.5 MHz, CDCl3, d): 8.3 (s, N3P3), 61.9 (s, P1), 62.8 (s, P2).
1H-NMR (300 MHz, CDCl3, d): 1.35 (m, 2H, C
(3)H2), 1.61 (m, 4H,
C(4)H2, C
(2)H2), 1.88 (m, 1H, C
(6)H2), 2.03 (m, 2H, C
(1)H2CO),
2.42 (m, 1H, C(6)H2), 2.72 (t, 2H, CH2Ar), 3.13 (m, 2H, C
(7)H2S),
3.28–3.50 (m, 48H, C(5)H–S, CH2NH, P1,2–N–CH3), 5.40 (s, 1H,
NH), 7.01 (m, 14H, CT
2H, C0
2H, CT
3H), 7.25 (m, 20H, C1
2H),
7.66 (m, 45H, C0
3H, C1
3H, CHQN–N). 13C{1H}-NMR (75.5 MHz,
CDCl3, d): 25.3 (C
(2/4)H2), 28.9 (C
(3)H2), 31.8 (d,
2JCP = 13.1 Hz,
P2–N–CH3), 33.1 (d,
2JCP = 12.9 Hz, P1–N–CH3), 34.6 (C
(2/4)H2),
35.1 (CH2Ar), 36.4 (C
(1)H2), 38.5 (C
(7)H2S), 40.3 (C
(6)H2), 40.5
(CH2NH), 56.5 (C
(5)H–S), 121.0 (CT
2), 121.4 (d, 3JCP = 6.2 Hz,
C0
2), 121.9 (d, 3JCP = 4.3 Hz, C1
2), 128.3 (C0
3), 128.8 (C1
3),
129.8 (CT
3), 131.6 (C1
4), 131.9 (C0
4), 135.9 (CT
4), 138.9
(m, CHQN–N–P1), 140.6 (d,
2JCP = 18.7 Hz, CHQN–N–P2),
151.4 (m, C0
1), 151.8 (d, 2JCP = 7.2 Hz, C1
1), 172.6 (NCO).
Bifunctional dendrimer 6-G2. In a Schlenk tube, 1.00 g of
compound 5-G2 (0.231 mmol, 1.0 eq.) was dissolved in 150 mL
of THF to which 650 mL of N,N-diethylethylenediamine
(4.59 mmol, 19.9 eq.) was added dropwise. The reaction was
left to stir overnight at room temperature. The precipitate was
washed twice with dry THF, yielding 1.00 g (0.15 mmol, 65%) of
dendrimer 6-G2 as a pale yellow solid.
31P{1H}-NMR (121.5
MHz, CDCl3, d): 8.9 (s, N3P3), 62.4 (s, P1), 70.2 (s, P2).
1H-NMR
(300 MHz, CDCl3, d): 1.26 (t,
3JHH = 6.9 Hz, about 15H,
NCH2CH3), 1.30 (t,
3JHH = 6.9 Hz, about 105H, N
+CH2CH3),
1.40 (m, 2H, C(3)H2), 1.51 (m, 4H, C
(4)H2, C
(2)H2), 1.85 (m, 1H,
C(6)H2), 2.10 (m, 2H, C
(1)H2CO), 2.36 (m, 1H, C
(6)H2), 2.79
(q, 3JHH = 6.9 Hz, about 10H, NCH2CH3), 2.86 (m, 2H, CH2Ar),
3.07 (2H, C(7)H2S), 3.20–3.40 (m, about 198H, C
(5)H–S, CH2N,
N+CH2CH3, P1,2–N–CH3), 6.90 (m, 2H, CT
2), 7.00 (m, 10H, C0
2),
7.11 (m, 2H, CT
3), 7.25 (m, 20H, C1
2), 7.60–7.95 (m, 45H, C0
3,
C1
3, CHQN–N–P1,2).
13C{1H}-NMR (75.5 MHz, CDCl3, d): 7.9
(N+CH2CH3), 9.7 (NCH2CH3), 25.1 (C
(2/4)H2), 28.5 (C
(3)H2), 31.3
(d, 2JCP = 9.4 Hz, P2–N–CH3), 32.5 (d,
2JCP = 12.2 Hz, P1–N–CH3),
34.4 (C(2/4)H2), 35.6 (CH2Ar), 36.2 (CH2–N–P2), 36.4 (C
(1)H2), 38.1
(C(7)H2S), 40.1 (C
(6)H2, CH2NHCO), 49.5 (N–CH2CH3), 52.2
(d, 3JCP = 6.9 Hz, P1–N–CH2CH2), 56.3 (C
(5)H–S), 121.0 (C0
2,
CT
2), 121.4 (C1
2), 128.0 (C1
3), 128.3 (C0
3), 130.0 (CT
3), 132.6 (C0
4),
133.3 (C1
4), 137.5 (d, 2JCP = 13.4 Hz, CHQN–N–P1,2), 151.0
(m, C0
1, CT
1, C1
1), 175.0 (NCO).
Bifunctional dendrimer 4-G2. In a Schlenk tube, 4.00 g of
5-G2 (0.916 mmol, 1.0 eq.), 2.45 g of p-hydroxybenzaldehyde
(20.1 mmol, 22 eq.) and 11.92 g of Cs2CO3 (36.6 mmol, 40 eq.)
were dissolved in 600 mL of THF. The reaction was left to stir
overnight at room temperature. The solution was filtered, its
volume was reduced and the dendrimer was precipitated from
pentane several times until all the excess of p-hydroxybenzaldehyde
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was removed. This quantitatively yielded dendrimer 4-G2 as a
pale yellow solid (5.54 g). 31P{1H}-NMR (121.5 MHz, CDCl3, d):
8.3 (s, N3P3), 60.3 (s, P2), 62.3 (s, P1).
1H-NMR (300 MHz, CDCl3,
d): 1.35 (m, 2H, C(3)H2), 1.66 (m, 4H, C
(4)H2, C
(2)H2), 1.88 (m,
1H, C(6)H2), 1.99 (t,
3JHH = 7.2 Hz, 2H, CH2CO), 2.34 (m, 1H,
C(6)H2), 2.66 (t,
3JHH = 7.2 Hz, 2H, CH2Ar), 3.07 (m, 2H, C
(7)H2S),
3.25–3.39 (m, 48H, C(5)H–S, CH2NH, P1,2–N–CH3), 5.75 (s, 1H,
NH), 6.80–7.08 (m, 14H, CT
2, CT
3, C0
2), 7.21 (m, 20H, C1
2), 7.36
(m, 40H, C2
2), 7.61 (m, 45H, C0
3, C1
3, CHQN–N), 7.83 (m, 40H,
C2
3), 9.90 (s, 20H, CHO). 13C{1H}-NMR (75.5 MHz, CDCl3, d): 25.3
(C(2/4)H2), 28.9 (C
(3)H2), 33.0 (2d,
2JCP = 12.8 Hz, P1,2–N–CH3), 34.5
(C(2/4)H2), 35.0 (CH2Ar), 36.3 (C
(1)H2), 38.5 (C
(7)H2S), 40.3 (C
(6)H2,
CH2NH), 56.5 (C
(5)H–S), 120.7 (CT
2), 121.3 (C0
2), 121.3 (d, 3JCP =
4.0 Hz, C1
2), 122.0 (d, 3JCP = 4.8 Hz, C2
2), 128.4 (C0,1
3), 129.6 (CT
3),
131.5 (C2
3), 132.0 (C0,1
4), 133.7 (C2
4), 135.9 (CT
4), 139.6 (2d, 2JCP =
15.1 Hz, CHQN–N–P1,2), 151.5 (2d,
2JCP = 7.1 Hz, C0,1
1), 155.1
(d, 2JCP = 7.2 Hz, C2
1), 172.8 (NCO), 190.7 (CHO).
Bifunctional dendrimer 7-G2. A mixture of 1.00 g of com-
pound 4-G2 (0.165 mmol, 1.0 eq.), 0.86 g of malonic acid
(8.27 mmol, 50 eq.) and 24.5 mL of piperidine (freshly distilled
over CaH2) was stirred in 15 mL of pyridine at 95 1C overnight.
After 15 minutes of reflux to remove the CO2, the mixture was
left to cool down and precipitated on ice-cold HCl (37%). The
precipitate was washed 3 times with water and twice with ether
before it was dried under reduced pressure. After dissolution in
water and subsequent ion exchange with 12 mL of 0.1996 M
NaOH (aq) (14.5 eq.) the solution was freeze-dried. 0.858 g of
dendrimer 7-G2 (0.117 mmol, 71%) was obtained as a pale
yellow solid. The NMR spectra were recorded before ion exchange
(COOH terminated dendrimers). 31P{1H}-NMR (121.5 MHz,
DMSO-d6, d): 8.4 (s, N3P3), 62.0 (s, P2), 62.4 (s, P1).
1H-NMR
(300 MHz, DMSO-d6, d): 1.23 (m, 2H, C
(3)H2), 1.36 (m, 4H, C
(4)H2,
C(2)H2), 1.75 (m, 1H, C
(6)H2), 1.90 (m, 2H, CH2CO), 2.18 (m, 1H,
C(6)H2), 2.57 (m, 2H, CH2Ar), 2.99 (m, 2H, C
(7)H2S), 3.12–3.59
(m, 48H, C(5)H–S, CH2NH, P1,2–N–CH3), 6.43 (d,
3JHH = 16.2 Hz,
20H, CHQCHCO2), 6.85 (m, 2H, CT
2H), 6.98 (m, 12H, CT
3H,
C0
2H), 7.18 (m, 60H, C1
2H, C2
2H), 7.53 (d, 3JHH = 16.2 Hz, 20H,
CHQCHCO2), 7.66 (m, 70H, C0
3H, C1
3H, C2
3H), 7.88 (m, 15H,
CHQN–N), 12.4 (COOH, 20H). 13C{1H}-NMR (75.5 MHz,
DMSO-d6, d): 25.4 (C
(2/4)H2), 28.7 (C
(3)H2), 33.4 (m, P1,2–N–CH3),
34.0 (C(2/4)H2), 34.5 (CH2Ar), 35.6 (C
(1)H2), 38.4 (C
(7)H2S), 56.5
(C(5)H–S), 119.8 (Ar–CHQCH), 120.6 (C0
2, CT
2), 121.8 (d, 3JCP =
4.8 Hz, C1
2, C2
2), 128.8 (CT,0,1
3), 130.3 (C2
3), 132.2 (C2
4), 132.5
(C0,1
4), 141.1 (m, CHQN–N–P1,2), 143.1 (Ar–CHQCH), 151.3
(d, 5JCP = 6.9 Hz, C0,1
1), 151.7 (d, 5JCP = 6.9 Hz, C2
1), 167.9
(COOH), 172.4 (NCO). (C(6)H2 and CH2NH hidden by DMSO).
Surface plasmon resonance spectroscopy
Dendrimers were adsorbed on template stripped gold, which
was prepared following the described procedure.51 The freshly
prepared gold samples were mounted onto a customized surface
plasmon resonance52 spectrometer and a 1 mg mL1 aqueous
solution of either 6-G1 or 7-G1 was added. The formation of the
dendrimer layers was followed in real time as an increase in SPR
reflectivity, which could be translated into a layer thickness. The
laser used was a HeNe laser with one spectral line at 632.8 nm.
Contact angle goniometry
The hydrophobicity of the diﬀerent coatings was measured with
an OCA 15+ (DataPhysics, Filderstadt, Germany) goniometer
equipped with a CCD camera and an electronic dosing unit. For
the determination of the contact angles, SCA 20 software was
used. The droplet volume was 3 mL and the water was degassed
before usage. Measurements were performed in 5-fold.
Cell experiments
A cell bank of a commercial cell line was created (HOB, human
hipbone osteoblasts, promocell, Heidelberg, Germany). HOB
cells were cultured at 37 1C and 5% CO2 in commercially
available HOB Growth medium, containing a promocell supple-
ment mix. The proliferation of the cells was followed by optical
inspection. The coated glass substrates were sterilized and
transferred to a petri-dish containing 3 mL of growth medium
and 2.0  104 HOB cells per mL. The growth medium was
changed every 48 h.
After about 300 hours, 80–100% confluence was reached and
cells were trypsinated and counted. 20 mL of the solution left
after trypsination were mixed with an equal amount of Trypan
Blue stain (GIBCO, 0.4%). The cell suspension was transferred
to a Neubauer cell counter. Subsequently, the relative number
of living cells (stained brightly blue) with respect to the total
number of cells (including dead cells, stained dark blue) was
determined.
After trypsination, the cells were transferred from the sample
surface to a 96-well Elisa plate. The cells were allowed to re-attach
to the Elisa walls for approximately 24 hours in HOB growth
medium. 100 mL medium was left in each Elisa well and mixed
with 100 mL of the assay solution (Caspase-Glos 3/7, Promega).
Subsequently, the Elisa plate was kept in the dark for 30 minutes
for the assay to reach full activity and then measured with a
Promega luminometer.
50 mL of an aqueous DAPI solution (40,6-diamidino-2-phenyl-
indole dihydrochloride. 2 mgmL1, Carl Roth GmbH, Karlsruhe,
Germany) were added to the cell culture. Cells were imaged
using an Olympus IX 70 microscope (Olympus, Center Valley,
USA). Images were recorded at 400-fold magnification using a
CCD camera.
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